NSAIDS + gout Flashcards

1
Q

acetylsalicylic acid (aspirin)

A

ASA covalently and irreversibly modifies both COX-1 and COX-2 by
acetylating serine-530 in the active site

Acetylation results in a steric block, preventing arachidonic acid from binding

Note: Acetylation of COX-2 retains the COX activity although the reaction
produces a different product, 15-R-HETE

T1/2: ASA: 20 min
salicylate: 3-5 h

irreversible blocks thrombocyte COX -> inability to transcribe new COX -> inhibiton for 8-10 days (life-time of that platelet)

  • Salicylate elimination is 1st order at low and moderate doses;
  • When total body salicylate > 600mg (>3.5g/d), elimination is zero order
    Acetylsalicylic acid (aspirin, ASA)
    irreversible COX inhibitor (COX-1>COX-2)

Effects:

Dose-Dependent Effects:
Low: < 300mg
blocks platelet aggregation

Intermediate: 300-2400mg/day
antipyretic and analgesic effects

High: 2400-4000mg/day
anti-inflammatory effects

Indications
art. thrombotic events (prevention and treatment)
mild/moderate pain, fever
inflammatory conditions (but high doses are required, not optimal)
decreases risk for TIA, unstable agina, coronary artery thrombosis, MI, thrombosis after bypass
long term: reduce risk of colon cancer

Kinetics:
good absorption, at low doses significant first pass metabolism
short half life, converted to salicylic acid (by esterases), which is further metabolized in the liver (at higher doses eliminated by zero-order kinetics - risk of accumulation and metabolic acidosis

Intoxication: Metab acidosis, respiratory depression, hyperpyrexia, coma. Treatment: NaHCO3 i.v. + symptomatic.

Other (non-acetylated) salicylates: salicylate (keratolytic + desinfectant), methyl salicylate (ointment to relieve joint/muscle pains, causes hyperemia), diflunisal (analgesic, weak antipyretic effect), 5-ASA (in IBD). magnesium choline salicylate, sodium salcylate, salicyl salicylate

SE (dose-dependant): uricosuric?, tinnitus, central hyperventilation, fever dehydration, metabolic acidosis, Vasomotor collapse, Come, Hypoprothrombinemia, renal and respiratory failure
hepatotoxicity (can be reversible, dose-dependent, or Reye syndrome in children with viral infection)
hyperuricemia (at the regular, 1-2 g/day dose, in gout not recommended),
hyperventillation,
bleeding (inhibition of platelets)

Aspirin overdose: restlessness, irritability, unorganized excessive speech, dizziness, confusion, abnormally excited mood, hallucination, drowsiness, loss of conciousness, double vision, uncontrolled shaking seizures, burning throat pain, vomiting pain, decreased urination

Contraindications:
A) Pregnancy 
B) Haemophilic patients
C) Hypersensitivity reaction to aspirin
D) Viral infections mainly in children
E) Peptic ulcers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

colchicin

A

inhibits migration of inflammatory cells, has considerable toxicity (vomiting, diarrhea, neurotoxicity, liver/kidney damage).

1st line

oral reabsorption and T1/2=9hours

excreted in bile and urine

relieves the pain and inflammation in 12-24 hours without altering the metabolism or exretion of urates and without other analgesic effect

binds the IC protein tubulin, thereby preventing polymerization into microtubules and leading to the inhibition of leukocyte migration and phagocytosis

also inhibits formation of leukotirene B4 and IL-1ß

indications: gout, also used between attacks as prophylaxis, prevents attacks of acute mediterrainean fever, may also be effective in sarcoid arthritis and in hepatic cirrhosis, treat and prevent pericarditis, pleurisy and coronary artery disease,

SE: mediated by inhibiting tubulin polymerization and cell mitosis, often cause diarrhea, occaisionally: nausea, vomiting and abdominal pain,
hepatic necrosis, acute renal failure and DIC and seizure have been observed
rarely: hair loss, BM suppression, peripheral neuritis, myopathy, (death)

mnost severe effects have been associated with IV admin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

allopurinol

A

purine structure, it inhibits xanthine oxidase and the hypoxanthine-xanthine-uric acid conversion

It is metabolized by xanthine oxidase to (book: alloxanthine?) oxipurinol, a long-acting active metabolite

used between attacks

80% oral bioavailability- serum T1/2 2 hourrs- once a day admin.

1st line in chronic gout

in the beginning colchecine or NSAIDs should be used to achieve level of allopurinol

SE: at the beginning of treatment can provoke acute attack + rarely causes severe allergic reaction (skin with maculopapular leasions)
Inhibits the metabolism of azathioprine and 6-mercaptopurine, increases their toxicity.
nausea, vomiting, diarrhea, peripheral neuritis, necrotizing vasculitis, BM suppression, aplastic anemia, Hepatic toxicity and interstitial nephritis, exfoliative dermatitis (isolated cases), rarely results in cataracts by binding to the lens

interactions: may increase the effect of cyclophosphamide, inhibits the metabolism of probenecid and oral anticoagulants and may increase hepatic iron deposition , cheotherapeutic purins must be reduced when given with allopurinol (75%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

rasburicase

A

recombinant urate oxidase (uricase) , catalyzes the conversion of uric acid to allantoin. Slowly infused for a few days during chemotherapy.
SE: allergy, fever. gout flare during initial treatment, may develope AB against rasburicase, anaphylaxis, nephrolithiasis, athralgia, muscle spasm, headache anemia, nausea, less frequent: Upper respiratory tract infection, peripheral edema, UTI, diarrhea

must be avoided in patients with G6PD DEFICIENCY DUE TO HEMOLYTIC ANEMIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

metamizole

A

Metamizole (noraminophenazone)
strong analgesic and antipyretic action after absorption
only mildly reduces inflammation
relative safe GI profile.
relaxes smooth muscles and can effectively alleviate visceral pains
it has limited use in most countries, due to its potential hematologic side effect (agranulocytosis, ~ 1:1.000.000, genetic predisposition?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

naproxen

A

long half life (14 h), used as analgesic (dysmenorrhea) and antiinflammatory agent

not a short half live

free fraction is higher in women than in male

but half life is similar in both sexes

available as a slow release formulation, oral suspension,topical solution and opthalmic solution

SE: rare cases of allergic pneumonitis, leukocytoclastic vasculitis, pseudoporphyria, GI bleeding 2x of ibuprofen

primarily used to alleviate inflammation and pain, usually inhibit COX-1 stronger than COX-2
do not accumulate in the body (except in synovial fluid).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ibuprofen

A

safer than ASA (can be given to children),
reduces pain and fever, at higher doses also inflammation
first choice drug to close patent ductus arteriosus in preterm babys, (don´t take it when pregnancy?)

low dosis primarily for analgesia

short half life

cream, gel and IV or oral

ibuprofen effects urine output less than indomethacine+ less fluid retention

primarily used to alleviate inflammation and pain, usually inhibit COX-1 stronger than COX-2
do not accumulate in the body (except in synovial fluid).

relative contraindication:

  1. nasal polyps
  2. angioedema
  3. bronchiospastic reactivity to aspirin

SE: aseptic meningitis (SLE patients) and fluid retention
ibuprofen antagonizes the irreversible platelet inhibitoion by aspirin if administered together. may also decrease the total anti-inflammatory effect
agranulocytosis and aplastic anemia (rare)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

(dex)ketoprofen

A

inhibits LOX as well, it has short half life

concomitant administration of probenecid elevates ketoprofen levels and prolongs its half life

primarily used to alleviate inflammation and pain, usually inhibit COX-1 stronger than COX-2
do not accumulate in the body (except in synovial fluid).

major adverse effects: on GI and CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

phenylbutazone

A

strong anti-inflammatory effect
considerable side effects, given only in severe inflammatory conditions, systemically for max 1 week (except Bechterew’s disease)
can also be used topically (may cause allergy).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

indomethacin

A
  • COX-1>COX-2, inhibits also the migration of inflammatory cells and proliferation of lymphocytes
  • also inhibits phospholipase A and C, reduce neutrophil migration and decreases B- and T-cell proliferation
  • strong antiinflammatory action, but due to its significant adverse effects (headache, ulcer, cytopenia, edema) it has limited use (severe inflammatory conditions, if other NSAIDs failed or cannot be used)
  • Effectively reduces fever in Hodgkin’s diseases

accelerates closure of DUCTUS arteriosus

ophthalmic preparation of conjunctivitis

indication: gingival inflammation (oral rinse preparation)

epidural injection for pain relief

SE: pancreatitis, headache (15-25%), dizziness, confusion, depression, renal papillary necrosis

Short acting strong antiinflammatory compounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

diclofenac

A

-COX-1 ≈ COX-2

  • used as antinflammatory agent and analgesic
  • it accumulates in synovial fluid, can be given to children
  • SE: elevation of serum aminotransferases, may increase the risk of thrombosis, CV effects

less GI ulcers than others (may be combined with misoprostol decreases ulcer risk but causes diarrhea)
elevated amino-transferases occurs more commonly with this drug
impairs renal blood flow and GFR

opthalmic preparation available

topical gel for solar keratosis

also: oral mouthwash, I.M., suppository

Short acting strong antiinflammatory compounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

meloxicam

A

meloxicam inhibits somewhat stronger COX-2. (less selective than celecoxib)

Long duration of action (20-70 h T1/2), mainly antiinflammatory drugs

selective COX-2 inhibitors do not affect platelet function while GI safety improves , increase incedence of edema, hypertension , MI

also inhibits synthesis of thromboxane A2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

celecoxib

A

are used mainly as antiinflammatory drugs, celecoxib may cause allergic reaction (sulfonamide structure)
(more) selective COX-2 (20x more than cox-1) inhibition
higher risk of cardiovascular events but fewer ulcer

because it is a sulphonamide it may cause rashes

interacts occasionally witgh warfarin because it is metabilzed by CYP2C9

selective COX-2 inhibitors do not affect platelet function while GI safety improves , increase incedence of edema, hypertension , MI

not effecting the housekkeping COX-1 found in GI, kidney and platelets

black box warning CV risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Probenecid, sulfinpyrazone

not on the list

A

they inhibit the reabsorption of uric acid in the proximal tubuli.
Second choice drugs, if allopurinol is poorly tolerated (allergy).

SE: urate stones, at the beginning of treatment they can provoke acute attack, probenecid potentiates the effect of penicillins and increases their toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

acute treatment of gout

A

NSAIDs (except: salicylates, tolmetine)
corticosteroids
Colchicine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

prophylactic treatment of gout

A

Inhibition of uric acid synthesis

Promotion of uric acid elimination

17
Q

Pharmacodynamic Effects of NSAIDs

A

Positive
Analgesic (0.3-0.6 g/day) - refers to the relief of pain by a mechanism other than
the reduction of inflammation (for example, headache);
- produce a mild degree of analgesia which is much less than the analgesia produced by opioid analgesics such as morphine

anti-inflammatory (3-5 g/day) - these drugs are used to treat inflammatory
diseases and injuries, and with larger doses - rheumatoid disorders

antipyretic (0.3-0.6 g/day) - reduce fever; lower elevated body temperature by
their action on the hypothalamus; normal body temperature is not reduced

antiplatelet (30-100 mg/day)- inhibit platelet aggregation, prolong bleeding time;
have anticoagulant effects

18
Q

side effects of NSAIDs

A
  • Gastric and bowel ulcers
  • Decrease in level of protective PGs + local destroying effect (majority of them have acidic characteristic)
  • Decreased renal function, water retention
  • Decreased kideny blood flow
  • In case of chronic administration the accumulation of NSAIDs and their direct toxic effect.
  • Cartilage damage
  • Decrease in level PGs results higher ROS level
  • Ductus Botallo closure (COX-1 inhibitors are contraindicated in the 3rd trimester)
  • Decrease of uterus contractility
  • Prolonged delivery, increased bleeding
  • Pseudoallergic reactions (rash, bronchoconstriction)
  • Enhanced synthesis of leukotriens
  • Cardiotoxicity
  • Thrombotic consquences – mainly in case of COX2 inhibitors
19
Q

side effects of NSAIDs

A
  • Gastric and bowel ulcers
  • Decrease in level of protective PGs + local destroying effect (majority of them have acidic characteristic)
  • Decreased renal function, water retention
  • Decreased kideny blood flow
  • nephrotoxicity due to inteference with autoregulation of renal blood flow
  • In case of chronic administration the accumulation of NSAIDs and their direct toxic effect.
  • Cartilage damage
  • Decrease in level PGs results higher ROS level
  • Ductus Botallo closure (COX-1 inhibitors are contraindicated in the 3rd trimester)
  • Decrease of uterus contractility
  • Prolonged delivery, increased bleeding
  • Pseudoallergic reactions (rash, bronchoconstriction)
  • Enhanced synthesis of leukotriens
  • Cardiotoxicity
  • Thrombotic consquences – mainly in case of COX2 inhibitors
  • hepatotoxiocity
  • CNS: headaches, tinnitus, dizziness (rarely aseptic meningitis)
  • CV: Fluid retention, hypertension, edema, (rarely MI and congestive HF)
  • GI: pain, dyspepsia, nausea, vomiting (rarely ulcer or bleeding)
  • hematologic: rare thrombocytopenia, neuropenia or even aplastic anemia
  • hepatic: abnormal liver function test, rare liver failure
  • pulmonary: asthma (exacerbation)
  • skin: rashes, pruritus
  • renal: insufficiency, renal failure, hyperkalemia, proteinuria
20
Q

Classification by COX selection

A

Non-specific inhibition of COX-1 results in gastrointestinal and platelet side effects

> 50x Cox-2 selective: rofecoxib, etoricoxib, valdecoxib, lumiracoxib

5-50x Cox-2 selective: etodolac, MELOXICAM, CELECOXIB, DICLOFENAC

<5-fold Cox-2 selective+ increasing COX-1 selectivity: fenoprofen, IBUPROFEN, tolometin, NAPROXEN, ASPIRIN, INDOMETHACIN, KETOPROFEN, flubiprofen, ketorolac

21
Q

COX-2 mediated

A

PGE2, PGI2, other chemical mediators: Inflammation, Pain, Fever

Vasodilation, antithrombosis

Inducible by pro-inflammatory stimuli (LPS, TNFa, IL-2, IFNg etc)

Inflammatory and neoplastic sites (small amounts in kidney, uterus, ovary, CNS [neocortex, hippocampus])

Pro-inflammatory and mitogenic functions (?neuronal plasticity)

22
Q

COX-2 mediated

A

PGE2, PGI2, other chemical mediators: Inflammation, Pain, Fever

Vasodilation, antithrombosis

Inducible by pro-inflammatory stimuli (LPS, TNFa, IL-2, IFNg etc)

Inflammatory and neoplastic sites (small amounts in kidney, uterus, ovary, CNS [neocortex, hippocampus])

Pro-inflammatory and mitogenic functions (?neuronal plasticity)

selective COX-2 inhibitors do not affect platelet function while GI safety improves , increase incedence of edema, hypertension , MI

23
Q

NSAIDs contraindication

A
Nursing and pregnancy
Serious bleeding
Allergy/ Asthma/ Angioedema
Impaired renal function
Drug (anticoagulant)

NSAID see the first letter

24
Q

half lifes of NSAIDs

A

Plasma Elimination Half Lives

Short Half Life (< 6 hours): 
more rapid effect and clearance 
Aspirin (0.25-0.33 hrs), 
Diclofenac (1.1 ± 0.2 hrs)
Ketoprofen (1.8 ± 0.4 hrs),
Ibuprofen (2.1 ± 0.3 hrs)
Indomethacin (4.6 ± 0.7 hrs) 
Long Half Life (> 10 hours):
slower onset of effect and slower clearance 
Naproxen (14 ± 2 hrs)
Sulindac (14 ± 8 hrs), 
Piroxicam (57 ± 22 hrs)
25
Q

Propionic derivatives

A

Most of them have short half life (except naproxen)
primarily used to alleviate inflammation and pain, usually inhibit COX-1 stronger than COX-2
do not accumulate in the body (except in synovial fluid).

ibuprofen, ketoprofen, tiaprofenic acid, flurbiprofen, naproxen

26
Q

Acetic acids

A

Short acting strong antiinflammatory compounds

Indometacin, diclofenac, aceclofenac, sulindac, etodolac, tolmetin, ketorolac

27
Q

Enolic acids (oxicam derivatives)

A

Long duration of action (20-70 h T1/2), mainly antiinflammatory drugs
Piroxicam and tenoxicam inhibit stronger COX-1 (more GI problems), while meloxicam inhibits somewhat stronger COX-2.

28
Q

Anthranilic acid derivatives (fenamates)

not on the list

A

Short acting antiinflammatory drugs and analgesics
GI side effects are common (e.g. diarrhea)
Mefenamic acid , niflumic acid, meclofenamic acid, flufenamic acid.

29
Q

Pyrazolone derivatives

A

metamizole , Phenylbutazone,

phenazone (ear drops), aminophenazone (reduces pain and fever), sulfinpyrazone (uricosuric drug), azapropazone, kebuzone, tribuzone

30
Q

Alkanones and Sulfonanilides

not on the list

A

Alkanones
Nabumetone, mainly antiinflammatory agent, less ulcerogenic (non-acidic prodrug + more selective COX-2 inhibition)

Sulfonanilides
Nimesulide, analgesic and antiinflammatory agent, inhibits stronger COX-2, may cause hepatotoxicity

31
Q

Substituated diaryl heterocyclic derivatives (coxibs)

A

(more) selective COX-2 inhibition
higher risk of cardiovascular events
Celecoxib and etoricoxib

Parecoxib is used primarily as an analgesic, given parenterally to treat postoperative pains, prodrug (active metabolite: valdecoxib)

32
Q

Further non-opioid analgesics

A

They reduce pain and fever, but do not inhibit COX (COX-3?)
do not possess antiinflammatory and antiplatelet properties
They are safe for the GI tract (non-acidic character).

Phenacetin, prodrug (paracetamol)

Paracetamol (acetaminophen)

33
Q

Phenacetin, prodrug (paracetamol)

A

chronic use may result in kidney damage and methemoglobinemia

34
Q

Paracetamol (acetaminophen)

A

short effect

mechanism unknown, weak COX inhibitor

widely used to alleviate pain and reduce fever
safe at lower doses, can be given to children and pregnants
At higher doses (6-8 g) demages the liver (toxic metabolite)
In alcoholics and patients with liver diseases can cause problems at lower doses
hepatotoxicity in overdose
n-acetylcysteine as antidote for hepatotoxicity

35
Q

additional possible ctions of NSAIDs

A
  1. inhibition of chemotaxis
  2. down-regulation of IL-1 production
  3. decreased production of free radicals and superoxide
  4. interference with calcium mediated intracellular events
  5. sensitivity of vessels to bradykinin
  6. and histamine
  7. affect lymphokine production from T-cell
  8. reverse the vasodilation of inflammation
36
Q

indications of NSAIDs

A

rheumatic diseases (RA, SpA, PsA, arthrites associated with IBD…)
Osteoarthritis
localized muscoskeletal syndromes: sprains, strains, low back pain)
gout (tolmetin is ineffective in gout)

37
Q

probenecis + sulfinpyrazone

not on the list

A

uricosuric agents